Hirsutism pathophysiology: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Hirsutism}}
{{Hirsutism}}
{{CMG}} {{AE}}
{{CMG}} {{AE}}; {{Ochuko}}


==Overview==
==Overview==

Revision as of 00:12, 14 September 2017

Hirsutism Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hirsutism from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Echocardiography or Ultrasonography

Treatment

Medical Therapy

Pharmacological therapy
Non-pharmacological therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hirsutism pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hirsutism pathophysiology

CDC on Hirsutism pathophysiology

Hirsutism pathophysiology in the news

Blogs on Hirsutism pathophysiology

Directions to Hospitals Treating Hirsutism pathophysiology

Risk calculators and risk factors for Hirsutism pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: ; Ogheneochuko Ajari, MB.BS, MS [2]

Overview

Hirsutism is a common disorder of the endocrine system, which affects about 10% of women approximately in the United States. It may indicate a serious or unserious medical condition seen as a serious cosmetic problem. Androgens are required for sexual hair development. Hirsutism can arise from increased androgen production or from increased sensitivity of the hair follicles to circulating androgens. [1]

Pathophysiology

Hair Growth Cycle

There are approximately 5 million hair follicles at birth in humans with about 80,000 to 150,000 of them on the scalp. The quality of hair is determined by hormones and other intrinsic characteristics of the hair follicle. There are various types of hair which include;

  • Vellus hair: These are fine, soft hair that are not pigmented. It covers most of the body before the pubertal period.
  • Terminal hair: These are long, coarse and pigmented. Pubertal androgens for example dihydrotestosterone (DHT) convert vellus hair to terminal hair.

The response of hair follicle to androgens and other factors such as local 5 alpha reductase activity determines the level of conversion of hair from the vellus type to terminal hair.

Androgens are essential for terminal hair and sebaceous gland development. Androgens transform the vellus hair into a terminal hair. In androgen-sensitive areas before puberty, the hair is vellus and the sebaceous glands are small. In response to increasing levels of androgens , pilosebaceous units become large terminal hair follicles in sexual hair areas or they become sebaceous follicles (sebaceous glands) in sebaceous areas. Androgens promote growth of sexual hair by recruiting a population of pilosebaceous units to switch from producing vellus hairs to initiating terminal hair growth.[2]

Phases of Hair Growth Cycle

There are 3 phases of hair growth cycle.

  • The hair growth phase (termed Anagen phase). This phase varies, depending on the body area affected. It is approximately 4 months for facial hair.
  • The involutional phase (Catagen phase). This phase is approximately 2-3 weeks.
  • The resting phase (Telogen phase). The hair shaft separates from the dermal papillae at the base of the follicle, which terminates growth.

Growth recommences with the formation of new hair shaft by the reactivation of the dermal papillae, thereby replacing the old hair. The hair growth cycle takes months to years to be completed, causing a delay in hair growth response to changes from effects of androgens. Differences in the activity of DHT, the hormone that acts on the hair follicle to produce terminal hair explains why women with the same plasma level testosterone which is a precursor of DHT, have different degrees of hirsutism.

It is speculated that insulin, at high enough concentration, stimulates the ovarian theca cells to produce androgens. There may also be an effect of high levels of insulin to activate the insulin-like growth factor-I (IGF-1) receptor in those same cells. Again, the result is increased androgen production.

References

  1. Breckwoldt M, Zahradnik HP, Wieacker P (1989). "Hirsutism, its pathogenesis". Hum Reprod. 4 (6): 601–4. PMID 2674189.
  2. Deplewski D, Rosenfield RL (2000). "Role of hormones in pilosebaceous unit development". Endocr. Rev. 21 (4): 363–92. doi:10.1210/edrv.21.4.0404. PMID 10950157.

Template:WH Template:WS